Fulgent Genetics

May is Ehlers-Danlos Syndromes (EDS) and Hypermobility Spectrum Disorders (HSD) Awareness Month, and we're marking it with significant expansions to two of our connective tissue panels.

Ehlers-Danlos syndromes and related connective tissue disorders can present with a wide range of symptoms across multiple body systems, often overlapping with other conditions. Identifying the underlying genetic etiology can shift care toward more personalized treatment and symptom management.

Two panel updates to know about:

🔶 Ehlers-Danlos Syndrome (EDS) Panel: 17 new genes added, for a new total of 39. Includes genes associated with all 13 EDS types.

🔶 Comprehensive Connective Tissue Disease Panel (renamed and expanded from our previous Connective Tissue Disease Panel): 56 new genes added, for a new total of 119. Covers genes associated with Ehlers-Danlos syndrome, Loeys-Dietz syndrome, Stickler syndrome, Marfan syndrome, and thoracic aortic aneurysm and dissection.

For patients still searching for answers, these expanded panels offer a more comprehensive look at the genetic landscape behind connective tissue disorders.

We've added carefully curated genes to both of our infertility panels, broadening coverage for more clinical impact:

✓ Female Infertility Panel:
41 genes added, for a new total of 143 — now including all OZEMA (Oocyte/Zygote/Embryo Maturation Arrest) genes

✓ Male Infertility Panel:
17 genes added, for a new total of 163

Pairing infertility testing with offers an even more complete picture for patients navigating their reproductive journey. One partner, every step.

Learn more:
https://web.fulgentgenetics.com/resources/testing-with-fulgent/reproductive-health